Alchemy Investments Acquisition Corp 1 (ALCYF) Preferred Stock Liabilities (2023 - 2026)
Alchemy Investments Acquisition Corp 1 (ALCYF) posted Preferred Stock Liabilities of $8.9 million for Q1 2026, up 1.65% sequentially from $8.7 million in Q4 2025, and down 25.8% YoY from $11.9 million in Q1 2025.
Alchemy Investments Acquisition Corp 1 (ALCYF) Preferred Stock Liabilities (2023 - 2026) Analysis & Trends
Alchemy Investments Acquisition Corp 1 has reported Preferred Stock Liabilities for 4 years, with the latest figure at $8.9 million in Q1 2026.
- Quarterly Preferred Stock Liabilities fell 25.8% year-over-year to $8.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $8.9 million (down 25.8% YoY) and the FY2025 annual result came in at $8.7 million, down 25.29% from the prior year.
- Preferred Stock Liabilities advanced to $8.9 million in Q1 2026 per ALCYF's latest filing, from $8.7 million in the prior quarter.
- Over five years, Preferred Stock Liabilities peaked at $125.3 million in Q3 2024 and troughed at $8.6 million in Q3 2025.
- A 4-year average of $65.8 million and a median of $64.8 million in 2023 frame the typical range for Preferred Stock Liabilities.
- The sharpest annual moves came in 2024 and 2025: Preferred Stock Liabilities advanced 5.35% in 2024, then slumped 93.17% in 2025.
- Over 4 years, Preferred Stock Liabilities stood at $120.6 million in 2023, then slumped by 90.33% to $11.7 million in 2024, then retreated by 25.29% to $8.7 million in 2025, then climbed by 1.65% to $8.9 million in 2026.
- According to Business Quant data, Preferred Stock Liabilities over the past three periods registered $8.9 million, $8.7 million, and $8.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Stock Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Oxley Bridge Acquisition | 585.76 Mn | 585.76 Mn | - | 260.50 Mn |
| 2 | Launch Two Acquisition | 557.86 Mn | 557.86 Mn | - | 245.51 Mn |
| 3 | Drugs Made In America Acquisition | 507.00 Mn | 507.00 Mn | - | 513.88 Mn |
| 4 | Cantor Equity Partners IV | 468.00 Mn | 468.00 Mn | - | 464.77 Mn |
| 5 | GP-Act III Acquisition | 401.06 Mn | 401.06 Mn | - | 98.24 Mn |
| 6 | Aldel Financial | 397.49 Mn | 397.49 Mn | - | 247.40 Mn |
| 7 | Republic Digital Acquisition | 389.25 Mn | 388.51 Mn | - | 313.51 Mn |
| 8 | Gores Holdings X | 385.06 Mn | 384.87 Mn | - | 373.78 Mn |
| 9 | Agriculture & Natural Solutions Acquisition | 377.29 Mn | 377.04 Mn | - | 376.71 Mn |
| 10 | Alchemy Investments Acquisition Corp 1 | 42.65 Mn | 42.57 Mn | - | 8.86 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.86 Mn |
| Dec 31, 2025 | 8.71 Mn |
| Sep 30, 2025 | 8.56 Mn |
| Jun 30, 2025 | 12.15 Mn |
| Mar 31, 2025 | 11.94 Mn |
| Dec 31, 2024 | 11.66 Mn |
| Sep 30, 2024 | 125.34 Mn |
| Jun 30, 2024 | 123.73 Mn |
| Mar 31, 2024 | 122.14 Mn |
| Dec 31, 2023 | 120.56 Mn |
| Sep 30, 2023 | 118.98 Mn |
| Jun 30, 2023 | 117.45 Mn |